DOJ set to conclude preliminary probe in 4th batch of Dengvaxia raps

Published November 8, 2019, 3:34 PM

by AJ Siytangco

By Jeffrey Damicog

The Department of Justice (DOJ) is expected to wrap up this December its preliminary investigation over the fourth batch of complaints concerning those who received shots of the anti-dengue vaccine Dengvaxia.

Department of Justice (MANILA BULLETIN)
Department of Justice (MANILA BULLETIN)

Meanwhile, the DOJ the panel of prosecutors conducting the preliminary investigation of the fourth batch of complaints has set two more hearing dates this November 18 and December 13.

“Submitted for resolution na ito after nun (the case will be submitted for resolution after that),” said Senior Assistant State Prosecutor Eden Wakay-Valdes held at the DOJ on Friday (November 8).

On November 18, among the respondents named in the complaints, two will be filing their respective rejoinders, while, the Public Attorney’s Office (PAO) who represent the complainants will submit its reply to the counter-affidavits of five other respondents.

Those same five respondents, who happened to be executives of Dengvaxia manufacturer Sanofi Pasteur living outside the Philippines, will also be submitting rejoinders on December 13.

The fourth batch concerned the deaths of 13 school children, and the suffering 11-year-old survivor Mark Joseph Estandarte went through.

The 12 dead children were Aldrid Aberia, Micaella Mainit, Eira Mae Galoso, Riceza Salgo, Leiden Alcabasa, Jonnel Dacquel, Kenchie Ocfemia, Angelica Pulumbarit, John Marky Ferrer, Maricel Manriza, Charmel Flordeliz and Annaliza Silverio.

In the complaints filed by the families of the 13 victims, the respondents were accused of accused of reckless imprudence resulting to homicide under Article 365 of the Revised Penal Code; torture resulting in the death of a person and torture committed against children under Republic Act 9745, the Anti-Torture Act of 2009; and for violating RA 7394, the Consumer Act of the Philippines, particularly, the mislabeling of drugs and devices, liability for defective products, and liability for product and service imperfection.

Among the respondents named in the complaints were former Health Secretary and current Iloilo First District Rep. Janette Garin and Health Secretary Francisco Duque.